Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Aug;46(8):2365-72.
doi: 10.1128/AAC.46.8.2365-2372.2002.

Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action

Karen K Biron  1 , Robert J Harvey, Stanley C Chamberlain, Steven S Good, Albert A Smith 3rd, Michelle G Davis, Christine L Talarico, Wayne H Miller, Robert Ferris, Ronna E Dornsife, Sylvia C Stanat, John C Drach, Leroy B Townsend, George W Koszalka
Affiliations

Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action

Karen K Biron et al. Antimicrob Agents Chemother. 2002 Aug.

Abstract

Benzimidazole nucleosides have been shown to be potent inhibitors of human cytomegalovirus (HCMV) replication in vitro. As part of the exploration of structure-activity relationships within this series, we synthesized the 2-isopropylamino derivative (3322W93) of 1H-beta-D-ribofuranoside-2-bromo-5,6-dichlorobenzimidazole (BDCRB) and the biologically unnatural L-sugars corresponding to both compounds. One of the L derivatives, 1H-beta-L-ribofuranoside-2-isopropylamino-5,6-dichlorobenzimidazole (1263W94), showed significant antiviral potency in vitro against both laboratory HCMV strains and clinical HCMV isolates, including those resistant to ganciclovir (GCV), foscarnet, and BDCRB. 1263W94 inhibited viral replication in a dose-dependent manner, with a mean 50% inhibitory concentration (IC(50)) of 0.12 +/- 0.01 microM compared to a mean IC(50) for GCV of 0.53 +/- 0.04 microM, as measured by a multicycle DNA hybridization assay. In a single replication cycle, 1263W94 treatment reduced viral DNA synthesis, as well as overall virus yield. HCMV mutants resistant to 1263W94 were isolated, establishing that the target of 1263W94 was a viral gene product. The resistance mutation was mapped to the UL97 open reading frame. The pUL97 protein kinase was strongly inhibited by 1263W94, with 50% inhibition occurring at 3 nM. Although HCMV DNA synthesis was inhibited by 1263W94, the inhibition was not mediated by the inhibition of viral DNA polymerase. The parent benzimidazole D-riboside BDCRB inhibits viral DNA maturation and processing, whereas 1263W94 does not. The mechanism of the antiviral effect of L-riboside 1263W94 is thus distinct from those of GCV and of BDCRB. In summary, 1263W94 inhibits viral replication by a novel mechanism that is not yet completely understood.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Chemical structures of 1263W94 and BDCRB.
FIG. 2.
FIG. 2.
Effects of 1263W94, GCV, and BDCRB on HCMV DNA synthesis during a single-cycle infection of MRC-5 cells.
FIG. 3.
FIG. 3.
Synthesis and processing of high-molecular-weight HCMV DNA in HCMV-infected cells in the presence or absence of 1263W94, BDCRB, and GCV. Calculations from integrated band intensities are shown below the figure. Abbreviations: M, monomeric viral DNA; C, concatemeric viral DNA.
FIG. 4.
FIG. 4.
“BDCRB washout” experiment for determining the effects of 1263W94, BDCRB, and GCV on the processing of concatemeric HCMV DNA that had accumulated during 96 h in the presence of BDCRB. Calculations from integrated band intensities are shown below the figure. Abbreviations: M, monomeric viral DNA; C, concatemeric viral DNA.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Baldanti, F., E. Silini, A. Sarasini, C. Talarico, S. Stanat, K. Biron, M. Furione, F. Bono, G. Palu, and G. Gerna. 1995. A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate. J. Virol. 69:796-800. - PMC - PubMed
    1. Baldanti, F., M. Underwood, S. Stanat, K. Biron, S. Chou, A. Sarasini, E. Silini, and G. Gerna. 1996. Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS. J. Virol. 70:1390-1395. - PMC - PubMed
    1. Blanchard, J. 1981. Evaluation of the relative efficacy of various techniques for deproteinizing plasma samples prior to high-performance liquid chromatographic analysis. J. Chromatogr. 226:455-460. - PubMed
    1. Chamberlain, S., S. Daluge, and G. Koszalka. June 2000. Antiviral benzimidazole nucleoside analogues and a method for their preparation. U.S. patent 6077832.
    1. Chan, J., S. Chamberlain, K. Biron, M. Davis, R. Harvey, D. Selleseth, R. Dornsife, E. Dark, L. Frick, L. Townsend, J. Drach, and G. Koszalka. 2000. Synthesis and evaluation of a series of 2′-deoxy analogues of the antiviral agent 5,6-dichloro-2-isopropylamino-1-(β-l-ribofuranosyl)-1H-benzimidazole (1263W94). Nucleosides Nucleotides Nucleic Acids 19:101-123. - PubMed

MeSH terms